Changes are happening - please bear with us while we update our site. Click here to give us your advice and feedback.
Changes are happening - please bear with us while we update our site. Click here to give us your advice and feedback.
Fisher & Paykel Healthcare Corp Ltd (ASX: FPH) is a manufacturer, designer and marketer of products & systems for use in respiratory care, acute care and the treatment of obstructive sleep apnea. The company has been operating in the healthcare industry since the 60s. The healthcare business has been a separate entity since 2001 when the company split from its appliances business.
Top performing fund manager, Hyperion Asset Management, recently released an update on their Hyperion Australian Growth Companies Fund.
The S&P Dow Jones Indices has announced the changes to the various S&P/ASX Indices. The changes will happen on 21 September 2020.
Fisher & Paykel Healthcare Corp Ltd (ASX:FPH) shares are up almost 5% after providing an FY21 trading update.
The S&P/ASX 200 (INDEXASX: XJO) is expected to jump this morning, according to data from the Sydney Futures Exchange. Here’s everything you need to know.
Fisher & Paykel Healthcare (ASX:FPH) has announced its FY20 full year result for the 12 months to 31 March 2020.
One of the leaders in ASX share portfolios during the tough March quarter was Fisher & Paykel Healthcare Ltd (ASX: FPH), a global leader in the manufacture of respiratory humidifiers.
The Cochlear Limited (ASX: COH) share price was trading 19.25% lower today following the release of news it would suspend its profit guidance for FY20.
Fisher & Paykel Healthcare (ASX:FPH) has reported its half year result to 30 September 2019.
Australia’s share market, or the All Ordinaries Index (INDEXASX:XAO)(ASX:XAO), is currently up 0.77% at lunch.
